-
-
Beta-blockers and noncardiac surgery; prenatal medication exposure and risk of autism; reasons for statin discontinuations; and FDA actions.
-
Patients seen in emergency departments (ED) for acute chest pain who are deemed low risk for acute coronary syndrome (ACS) and relatively safe for discharge are often referred to their primary care physician (PCP) for follow-up.
-
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial was completed more than 10 years ago.
-
The Biventricular vs Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) trial tested the hypothesis that biventricular pacing (cardiac resynchronization therapy [CRT]) would be superior to right ventricular pacing in patients with mild-to-moderate heart failure, left ventricular systolic dysfunction, and an indication for full-time ventricular pacing.
-
-
In this paper, the authors report the results of a study that examined the impact of yoga training on patients with paroxysmal atrial fibrillation (AF). The authors enrolled 101 patients with paroxysmal AF who were on a stable medical regimen.
-
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
-
The prevalence and natural history of aortic stenosis (AS) are well known. However, there is a paucity of data about the natural history of combined AS and aortic regurgitation (AR). AS and AR confer differing types of stress on the left ventricle, and it stands to reason that the combination may result in worse outcomes than either AS or AR alone.
-
Newer biomarkers such as B-type natriuretic peptide (BNP) and high-sensitive troponins have been shown to be of prognostic value in patients with cardiovascular disease. These investigators from central Europe sought to determine if they were of value in risk stratification for non-cardiac surgery.